Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication

NCT00006578 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Ritonavir
DRUG: Abacavir sulfate
DRUG: Amprenavir
DRUG: Lamivudine
DRUG: Filgrastim

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)